Security key
98420N105
Xenon Pharmaceuticals Inc. - COMMON STOCK (XENE)
CUSIP: 98420N105
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 27,927,587
- Total 13F value
- $309,203,900
- Share change
- -32,659
- SEC-reported price per share
- $11.07
- Number of holders
- 79
- Value change
- -$546,988
- Number of buys
- 19
- Number of sells
- 32
- Shares outstanding
- 96,697,040
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
79
Top holders
10
XENE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Ownership snapshot
Top reported holders of XENE - Xenon Pharmaceuticals Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 3.6%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 3.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
3.6%
Avoro Capital Advisors LLC
2.9%
ORBIMED ADVISORS LLC
2.6%
FMR LLC
2.3%
ADAGE CAPITAL PARTNERS GP, L.L.C.
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
3.6%
|
$44,101,000
3,516,851 shares
|
— | 30 Jun 2020 |
| Avoro Capital Advisors LLC |
13F
Company
|
2.9%
|
$35,112,000
2,800,000 shares
|
— | 30 Jun 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.6%
|
$31,324,000
2,497,917 shares
|
— | 30 Jun 2020 |
| FMR LLC |
13F
Company
|
2.3%
|
$27,576,000
2,199,054 shares
|
— | 30 Jun 2020 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
2.1%
|
$25,394,000
2,025,000 shares
|
— | 30 Jun 2020 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
1.3%
|
$15,977,000
1,274,100 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
79
Shares
27,927,587
Rows available
79
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
78
Q3 2020 holders
79
Holder diff
1
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend